Tear Martix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 in Post-Lasik Ectasia.

Abstract

To estimate the concentrations of matrix metalloproteinase-9 (MMP-9) and tissue inhibitors of metalloproteinase-1 (TIMP-1) in the tear film of cases with post-Lasik ectasia (PLE) to spot any role of these mediators. Ophthalmology department, Benha University hospitals, Egypt. Twelve eyes of 12 patients with PLE, 30 eyes of 30 patients with KC, 25 eyes of 25 subjects with uncomplicated Lasik and finally 25 eyes of 25 healthy subjects as a control group were studied. Subjects with ocular surface diseases, previous ocular surgeries except for Lasik in PLE group and Lasik group, were excluded. All subjects had full ophthalmic examination and Pentacam imaging. The concentration of tear MMP-9 and TIMP-1 was measured by ELISA. Our results showed a significant elevation in the level of MMP-9 and a significant reduction in the level of TIMP-1 in tear samples from PLE cases (MMP-9 was 59.17±28.15ng/ml, and TIMP-1 was 110.3±50.6ng/ml) and also in KC cases (MMP-9 was 53.12±17.35ng/ml, and TIMP-1 was 105.8±56.3ng/ml) when compared to post-Lasik group (MMP-9 was 35.65±17.32ng/ml, and TIMP-1 was 155.2±39.4ng/ml) and control group (MMP-9 was 31.92±20.78ng/ml, and TIMP-1 was 162.5±48.2ng/ml). The results pointed to potential role of MMP-9 in the pathogenesis of PLE and also referred to a biochemical similarity between PLE and KC. More studies are needed in the future to investigate larger number of tear mediators.